Nipate
Forum => Kenya Discussion => Topic started by: Olekoima on October 30, 2014, 08:36:56 AM
-
(Reuters) - Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a program with funding from the Wellcome Trust.
A $5 million grant from the medical charity will allow several global partners, overseen by the World Health Organization (WHO), to gather essential safety data for the so-called rVSV-EBOV vaccine......
http://www.reuters.com/article/2014/10/29/us-health-ebola-vaccine-idUSKBN0II1I820141029
-
How timely. Ebola is usually such a rare thing. It is timely that so much money and drugs are suddenly available for it.